ISRCTN59497461已完成未知
A randomised, triple-arm study to compare the viral and immunological outcome of highly active anti-retroviral therapy during six versus 15 months versus no treatment in patients with primary human immunodeficiency virus-1 (HIV 1) infection
Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 173 人开始时间: 2007年2月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 173
研究概览
简要总结
2012 results in: https://www.ncbi.nlm.nih.gov/pubmed/22479156 [added 16/01/2019]
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Diagnosis of acute/recent human immunodeficiency virus-1 (HIV-1) infection: plasma HIV-1 ribonucleic acid (RNA) load detectable and/or detectable serum p24 antigen and one of the following:
- •1. Enzyme-linked immunosorbent assay (ELISA): HIV-1 specific antibodies negative, or
- •2. ELISA: low level antibodies or HIV-1 specific antibodies positive and a negative, incomplete or indeterminate Western Blot (antibodies against a maximum of three of the HIV specific proteins), or
- •3. ELISA: HIV-1 specific antibodies positive and positive Western Blot, but with documented negative HIV-1 ELISA in the preceding 180 days
排除标准
- •Does not comply with the above inclusion criteria
研究者
相似试验
已完成
不适用
A randomized, triple-arm study to compare the viral and immunological outcome of HAART during 6 versus 15 months versus no treatment in patients with primary HIV 1 infection.NL-OMON20081173
已完成
3 期
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study OneMultiple sclerosisNervous System DiseasesISRCTN21534255Genzyme Corporation (USA)581
已完成
不适用
2x2 factorial randomised phase III study comparing standard versus whole bladder volume radiotherapy with and without synchronous chemotherapy in muscle invasive bladder cancerBladder (advanced)CancerISRCTN68324339Individual Sponsor (UK)458
已完成
3 期
A new peritoneal dialysis fluid for Japan: A randomized non-inferiority clinical trial of safety and efficacyChronic renal failureUrological and Genital DiseasesISRCTN10007426Baxter Limited108
已完成
3 期
A new peritoneal dialysis fluid for Japan: A randomized non-inferiority clinical trial of safety and efficacyChronic renal failureISRCTN48112900Baxter Limited113